Isolated intramedullary neurosarcoidosis of the thoracic spine: case report and review of the literature by Schmidt, Meic H. & Duhon, Bradley S.
Isolated intramedullary neurosarcoidosis   1 
Isolated Intramedullary Neurosarcoidosis of the Thoracic Spine: Case Report 
and Review of the Literature 
Bradley S. Duhon, M.D.,
1
 Lubdha Shah, M.D.,
2
 and Meic H. Schmidt, M.D.
1 
1
Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake 
City, Utah 
2
Department of Radiology, University of Utah, Salt Lake City, Utah 
 
Corresponding Author: Meic H. Schmidt, M.D. 
Department of Neurosurgery 
Clinical Neurosciences Center 
University of Utah 
175 N. Medical Dr. East 
Salt Lake City, UT 84132 
Phone: (801) 581-6908 
Fax: (801) 581-4385 
Email: neuropub@hsc.utah.edu 
Acknowledgments:  We thank Kristin Kraus, M.Sc., for editorial assistance and Steven Chin, 

















anuscript          
University of Utah Institutional Repository  
Author Manuscript
Isolated intramedullary neurosarcoidosis   2 
Abstract 
Sarcoidosis can involve the central nervous system in approximately 5–15% of cases. Any part 
of the nervous system can be involved, so presentation can be quite varied. Isolated disease of 
the spinal cord is even less common and reports are limited to single cases and small series. 
Although in the setting of systemic disease the diagnosis can be made with skin or lymph node 
biopsy, isolated disease of the spinal cord presents a diagnostic challenge. We present a case of 
isolated intramedullary neurosarcoidosis of the distal thoracic spinal cord presenting with 
posterior column dysfunction. Imaging demonstrated T2 changes in the patient’s lower thoracic 
cord adjacent to disc herniation. Over time, however, his symptoms progressed despite 
decompression, and the abnormal region began to exhibit focal contrast enhancement. The 
persistence of symptoms as well as the new enhancement led us to perform a spinal cord biopsy, 
which demonstrated histopathological findings consistent with sarcoidosis. Further workup failed 
to reveal any evidence of systemic disease. Intramedullary sarcoidosis without systemic 
sarcoidosis is extremely rare. With its variable imaging appearance and inconsistent clinical 
manifestations, it can be difficult to diagnose. It should be considered in the differential 
diagnosis of a mass-like intramedullary lesion with progressive symptoms. Biopsy with 
histopathological correlation may be the only definite management option.  
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Sarcoidosis is a systemic, granulomatous disease most commonly involving the lymph nodes, 
skin, lungs, and eyes. Central nervous system (CNS) involvement (neurosarcoidosis) occurs in 
5–15% of cases, and  six to eight percent of patients with neurosarcoidosis have spinal cord 
involvement; however, among all patients with sarcoidosis, the incidence of isolated spinal cord  
is only 0.43% [3, 17].  
 
The cause of the disease process is unknown, and the hallmark of sarcoidosis is the presence of 
noncaseating granulomas found throughout the body [15, 31].
 
 Although radiographic findings 
and laboratory values may lead to the diagnosis, biopsy of the involved organ systems is the gold 
standard [7].  Spinal neurosarcoidosis can mimic an inflammatory demyelinating process both 
clinically and on imaging studies, particularly magnetic resonance imaging (MRI) [18].  
 
 
We present a case of isolated intramedullary sarcoidosis involving the distal thoracic spinal cord, 
which presented as lower extremity myelopathy and required spinal cord biopsy for diagnosis.  
Thorough workup had revealed no evidence of systemic disease, demonstrating an unusual 
presentation of sarcoidosis. We provide a review of imaging, laboratory studies, and 
histopathological findings useful for diagnosis of spinal neurosarcoidosis. 
 
Case Report 
This 48-year-old man had a history of lower back pain of 1.5-year duration. The pain was 
centered at the thoracolumbar region and was associated with shock-like sensations down the 
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progressed to include leg numbness (more pronounced on the right side than on the left), 
tingling, and weakness.  He described a “buzzing” sensation with poor position-sense in his 
lower extremities.  After one year of symptoms, the patient was evaluated by an outside 
physician, and nonenhanced MRI demonstrated a right paracentral disc protrusion at T10-11 
resulting in moderate central canal stenosis and deformity of the ventral cord. In addition, the 
cord showed mild fusiform expansion and hyperintensity on T2-weighted MRI, which was 
concerning for spondylotic compressive myelopathy (Figure 1).   
 
The patient underwent thoracic laminectomy and fusion to decompress the stenotic level. Despite 
surgery, his symptoms progressed until he began to have difficulty with walking.  At the time of 
symptom onset, he was able to run 1.5 miles, but by the time of presentation he was having 
significant difficulty with ambulation and now required a cane.  The progression of symptoms 
prompted referral to our institution five months after surgery. 
 
Upon examination, the patient demonstrated full strength on confrontational testing but had 
difficulty with tandem gait.   In addition, he had positive findings on Romberg testing.  He had 
normal reflexes in his left leg and right patella, but an absent right Achilles reflex.  His toes were 
downgoing bilaterally, and he had no clonus.  His sensory examination revealed decreased 
vibratory sense down to the knees bilaterally and decreased proprioception in his left lower 
extremity.  These neurologic findings prompted follow-up MRI with contrast enhancement. 
Enhanced MRI exhibited persistent mild expansion of a short segment of the distal thoracic cord 
at the T10-11 level with ill-defined intramedullary T2 hyperintensity and patchy enhancement 
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There was also persistent moderate canal stenosis at the T0-T11 level. Because the clinical 
symptoms and neuroimaging abnormalities had persisted despite surgical decompression, the 
diagnosis of spondylotic compressive myelopathy was questioned and other differential entities 
such as neoplasm, inflammatory disease, and demyelinating disease were considered.  
 
Initial laboratory work-up including lumbar puncture revealed that the patient had a mildly 
elevated protein level (55 mg/dL), a normal IgG index (0.5 mg/dL), negative oligoclonal bands, 
normal angiotensin converting enzyme (ACE) level (2.0 U/L), and no malignant cells on CSF 
cytology studies. His CSF also demonstrated 29 red blood cells and 6 white blood cells/µL with 
99% lymphocytes. Serum ACE was ultimately found to be elevated to 71 U/L, but it was only 
drawn after the histopathological diagnosis had been made via biopsy. 
 
Because it was not possible to make a definitive diagnosis based on laboratory studies, a repeat 
thoracic laminectomy for spinal cord biopsy was offered 9 months after the patient’s previous 
surgery.  Despite the risks of an intramedullary biopsy, this was thought to be the best option for 
diagnosis. Intraoperatively, the thoracic cord had a normal external appearance with the 
exception of its significantly enlarged size. A midline dorsal myelotomy was created, revealing a 
slightly gray appearance of the spinal cord internally. Specimens were sent for pathological 
analysis and, after dural closure, a posterior arthrodesis with pedicle screw fixation was 
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The patient initially had a worsening of his sensation and proprioception in his lower extremities, 
but this improved throughout his postoperative stay, and he was walking independently upon 
discharge 4 days later. At his 1-month follow-up visit, he exhibited full strength in his legs, and 
his sensory deficits had returned to his preoperative state but no better. Results from the biopsy 
demonstrated non-necrotizing granulomatous disease consistent with sarcoidosis (Figure 4).   
After the histological diagnosis, treatment was initiated with prednisone and azathioprine [1].  
The patient’s symptoms improved over the next 3 months.  At 1-year follow-up, the thoracic  
MRI scan showed near-resolution of the T2 hyperintensity and cord expansion in the distal spinal 
cord. Additionally, the patient’s symptoms were stabilized with mild numbness in his feet.  At 
the most recent follow-up at 18 months, he had discontinued use of all immunosuppressants 
against medical advice because of the side effects.  He continued to have significant “buzzing” in 
his legs with exertion, but this was relatively well controlled with gabapentin.  He is scheduled to 
undergo imaging yearly. 
 
Discussion 
Neurosarcoidosis was first reported in 1904 [32].
   
Since then, it has become a well-described 
manifestation of sarcoidosis. Spinal cord involvement is more prevalent in the cervical spine 
(56%) than in the thoracic (37%) and lumbosacral (7%) spine [16, 17].  
   
Spinal sarcoidosis can 
present with varied symptoms, including weakness, paresthesias, myelopathy, demyelinating 
syndrome [18], facial nerve paralysis [28], bowel, bladder, or sexual disturbances, back pain [10, 
26], or even radicular pain [30]. The characteristic demographic of spinal sarcoidosis is a male 
patient, 20–40 years of age, of Northern European or African descent.  In systemic sarcoidosis 
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The imaging findings of CNS sarcoidosis can mimic other disease processes such as multiple 
sclerosis, metastasis, primary glial neoplasms, and extra-axial neoplasms. The imaging spectrum 
for neurosarcoidosis in the brain includes periventricular and subcortical white matter lesions on 
fluid-attenuated inversion recovery (FLAIR) and T2-weighted images, multiple supra- and 
infratentorial enhancing lesions, solitary intra- or extra-axial mass, and leptomeningeal 
enhancement [28, 33].  Spinal sarcoidosis most commonly demonstrates smooth or nodular 
leptomeningeal enhancement with patchy peripheral cord enhancement because of infiltration of 
the perivascular spaces; however, spinal sarcoidosis has a myriad of imaging manifestations 
from diffuse intramedullary T2 hyperintensity to mass-like intramedullary enhancement. There 
may be osseous involvement with multiple lytic or mixed lytic–sclerotic lesions. Fusiform cord 
enlargement initially is followed by atrophy in the chronic stages. The combination of 
leptomeningeal and peripheral intramedullary enhancement is most suggestive of spinal 
sarcoidosis. In isolated spinal cord involvement, meningeal or parenchymal biopsy may be 
required. Treatment with steroids may result in decreased enhancement. Although many sarcoid-
related MRI abnormalities are not associated with correlating symptoms, there is a high degree 
of concordance between changes in clinical symptoms and MRI abnormalities, particularly in the 
cranial vault and spinal cord [29]. 
 
The imaging differential diagnosis of isolated intramedullary sarcoidosis includes neoplasm, 
demyelinating processes (such as multiple sclerosis), post-infectious myelitis, spondylotic 

















anuscript          
University of Utah Institutional Repository  
Author Manuscript
Isolated intramedullary neurosarcoidosis   8 
laboratory and radiographic findings are clear, the diagnosis may be suggested; however, 
histopathological confirmation is necessary to make a definitive diagnosis [33]. 
 
Laboratory work-up for spinal sarcoidosis should include CSF evaluation. CSF abnormalities are 
seen in approximately 80% of cases of neurosarcoidosis; however, these findings are quite varied 
and nonspecific [33].
  
Cell count, protein, glucose, and ACE levels should be obtained. Cell 
count typically shows few, if any, cells with a lymphocytic predominance. An elevated protein 
level is the most common finding. Even CSF oligoclonal bands can be identified in 36% of cases 
[24, 25, 33].  Serum and CSF ACE levels are often considered valuable in the diagnosis of 
neurosarcoidosis. Elevated levels of either are supportive of the diagnosis, but true-positive yield 
is quite low (24–75%) [9, 22, 23].  False positives can be seen in other disease processes 
including tuberculosis or malignancy [2, 21]. 
 
The histopathological hallmark of sarcoidosis is the noncaseating granuloma with multinucleated 
giant cells.  CNS lesions may be smaller and have fewer giant cells within more poorly formed 
granulomas, which may increase the likelihood of a negative biopsy result [18, 27].
  
Another 
pitfall of biopsy can be frozen sections mimicking tumor. [19, 20].
   
In cases in which 
leptomeningeal biopsies are obtained, the arachnoid is often infiltrated with lymphocytes and the 
typical granulomas. The proposed mechanism by which sarcoidosis becomes intramedullary is 
via extension through perivascular spaces [10]. 
 
Treatment of neurosarcoidosis is based on immunosuppressant therapy, with a goal of 
suppression rather than cure.
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immunosuppressant therapy, although stronger immunosuppressants, such as methotrexate, 
cyclosporine, cyclophosphamide, azathioprine, and chlorambucil, have also been used [1].
   
Most 
outcomes data in neurosarcoidosis are based on anecdotal reports and small series in the absence 
of prospective trials with response to treatment being variable. Because of the suggested link 
between tumor necrosis factor-α (TNF-α) and disease, monoclonal antibodies to TNF-α have 
been studied for the treatment of refractory sarcoidosis [5, 6, 8, 11, 12],
 
although this therapy 
remains experimental. Surgery (especially for intramedullary lesions) is reserved for diagnostic 
biopsy, as surgical resection is morbid and not beneficial [4].
  
Localized radiation has also been 
used and may provide temporary relief [14].
  
Regardless of treatment, prognosis of 
neurosarcoidosis is quite variable. The presence of neurological symptoms at presentation has 
been associated with poor outcome, but steroid therapy in spinal disease may be linked to a more 
favorable outcome [13, 18].
 
 
Intramedullary sarcoidosis is a rare entity, and it is exceedingly rare without systemic 
sarcoidosis. Its variable imaging appearance and inconsistent clinical manifestations can pose a 
diagnostic dilemma. Although rare, isolated spinal cord neurosarcoidosis should be in the 
differential diagnosis when evaluating patients with myelopathy, especially if the patient does 
not improve or worsens despite a good decompression. In these patients, open biopsy may be 
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Figure 1. (A) Sagittal T2-weighted MRI demonstrates mild fusiform enlargement of the spinal 
cord extending from the T9-T10 level to the T11-T12 level. (B) Axial T2-weighted MRI reveals 
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Figure 2. (A) Sagittal T2-weighted MRI shows persistent mild cord expansion at the T10-T11 
level. There is central T2 hyperintensity spanning the T9-T10 to the T10-T11 levels. The signal 
abnormality has tapered polar morphology. (B) Sagittal T1-weighted contrast-enhanced MRI 
depicts patchy intramedullary enhancement at the T10-T11 level. No leptomeningeal 
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Figure 3.  Anteroposterior (A) and lateral (B) radiographs demonstrate posterior decompression 
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Figure 4. High-magnification hematoxylin and eosin-stained section demonstrating perivascular 
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